AU2002342858A1 - Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus - Google Patents
Human high-affinity antibody fragments for essential proteins of the hepatitis-c virusInfo
- Publication number
- AU2002342858A1 AU2002342858A1 AU2002342858A AU2002342858A AU2002342858A1 AU 2002342858 A1 AU2002342858 A1 AU 2002342858A1 AU 2002342858 A AU2002342858 A AU 2002342858A AU 2002342858 A AU2002342858 A AU 2002342858A AU 2002342858 A1 AU2002342858 A1 AU 2002342858A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- virus
- antibody fragments
- affinity antibody
- human high
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 title 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10123041A DE10123041A1 (en) | 2001-05-11 | 2001-05-11 | New single-chain human antibody fragment, useful for treating or diagnosing hepatitis C virus infection, has affinity for an essential viral protein |
DE10123041.9 | 2001-05-11 | ||
PCT/EP2002/005227 WO2002093519A2 (en) | 2001-05-11 | 2002-05-13 | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002342858A1 true AU2002342858A1 (en) | 2002-11-25 |
Family
ID=7684487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002342858A Abandoned AU2002342858A1 (en) | 2001-05-11 | 2002-05-13 | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002342858A1 (en) |
DE (1) | DE10123041A1 (en) |
WO (1) | WO2002093519A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60237704D1 (en) | 2001-10-16 | 2010-10-28 | Government Of The Us Secretary | NEUTRALIZING ANTIBODIES TO HIV WITH A WIDE CROSS-REACTION SELECTED BY ENV-CD4-CO RECEPTOR COMPLEXES |
EP1504034B1 (en) | 2002-05-06 | 2012-12-12 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
WO2003092630A2 (en) | 2002-05-06 | 2003-11-13 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
CA2553788A1 (en) * | 2003-09-29 | 2006-07-06 | The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services | Immunoglobulins whith potent and broad antiviral activity |
EP2338997A1 (en) * | 2005-03-25 | 2011-06-29 | National Research Council Of Canada | Method for isolation of soluble polypeptides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6171782B1 (en) * | 1987-11-18 | 2001-01-09 | Chiron Corporation | Antibody compositions to HCV and uses thereof |
US6194140B1 (en) * | 1990-04-04 | 2001-02-27 | Chiron Corporation | HCV NS3 protein fragments having helicase activity and improved solubility |
US6190864B1 (en) * | 1991-05-08 | 2001-02-20 | Chiron Corporation | HCV genomic sequences for diagnostics and therapeutics |
DE19531226C1 (en) * | 1995-08-24 | 1997-04-03 | Immuno Ag | Pharmaceutical compsn. for prevention or treatment of viral disease |
-
2001
- 2001-05-11 DE DE10123041A patent/DE10123041A1/en not_active Withdrawn
-
2002
- 2002-05-13 WO PCT/EP2002/005227 patent/WO2002093519A2/en not_active Application Discontinuation
- 2002-05-13 AU AU2002342858A patent/AU2002342858A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE10123041A1 (en) | 2002-11-28 |
WO2002093519A2 (en) | 2002-11-21 |
WO2002093519A3 (en) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002338015A1 (en) | Human CDR-grafted antibodies and antibody fragments thereof | |
AU2002349727A1 (en) | Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof | |
AU2002362710A1 (en) | Use of thymulin-like peptides for making pain-relieving medicines | |
AU2002312303A1 (en) | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease | |
AU2002237195A1 (en) | Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus | |
AU2002257088A1 (en) | Immunoglobulin superfamily proteins | |
AU2002300166A1 (en) | Process for the Preparation of Peptides | |
AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
AU2002365269A1 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
AU2002342858A1 (en) | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus | |
AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
AU2002305903A1 (en) | Carbohydrate-associated proteins | |
AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
AU2002311620A1 (en) | Methods of making and using expression constructs for the expression of recombinant proteins | |
AU2002354363A1 (en) | Method of activating protein | |
AU2002217820A1 (en) | Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection | |
AU2002346056A1 (en) | Viral proteins capable of binding lar | |
AU2003214721A1 (en) | Fragments of apoptin | |
AU2002364757A1 (en) | Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases | |
AU2003226907A1 (en) | Method for the preparation of recombinant mammalian heparin-binding protein (hbp) | |
AU2002365148A1 (en) | Human ras interacting protein | |
AU2002254595A1 (en) | Method for enhancing the translation and expression of recombinant proteins | |
AU2002328413A1 (en) | Method for Determining Target Protein of Medicament | |
AU2002357850A1 (en) | Neurotransmission-associated proteins | |
AU2002257630A1 (en) | Human mrp5-like protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |